Literature DB >> 22690393

France launches new drug regulatory agency.

Martine Lochouarn.   

Abstract

Mesh：

Year:  2012        PMID： 22690393     DOI： 10.1016/s0140-6736(12)60927-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors:  Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-09-26

2.  Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.

Authors:  Ali T Taher; John B Porter; Antonis Kattamis; Vip Viprakasit; M Domenica Cappellini
Journal:  Drug Des Devel Ther       Date:  2016-12-15       Impact factor: 4.162

3.  Conflict of interest policies at Belgian medical faculties: Cross-sectional study indicates little oversight.

Authors:  Lucas Bechoux; Oriane De Vleeschouwer; Cécile Vanheuverzwijn; Florence Verhegghen; Alizée Detiffe; Fabian Colle; Catherine Fallon; François Thoreau
Journal:  PLoS One       Date:  2021-02-10       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.